Krilogy Financial LLC acquired a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 7,093 shares of the financial services provider’s stock, valued at approximately $1,295,000.
Several other large investors have also recently bought and sold shares of MRSH. Solstein Capital LLC purchased a new position in shares of Marsh & McLennan Companies in the 4th quarter valued at about $25,000. SHP Wealth Management purchased a new stake in Marsh & McLennan Companies during the fourth quarter worth approximately $26,000. KERR FINANCIAL PLANNING Corp purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $27,000. Golden State Wealth Management LLC acquired a new stake in Marsh & McLennan Companies during the fourth quarter worth approximately $27,000. Finally, Atlas Capital Advisors Inc. purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth approximately $28,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Insider Activity at Marsh & McLennan Companies
In related news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $161.71, for a total transaction of $2,693,441.76. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This trade represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on MRSH
Marsh & McLennan Companies Trading Down 2.3%
Shares of MRSH opened at $162.22 on Friday. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11. Marsh & McLennan Companies, Inc. has a fifty-two week low of $156.60 and a fifty-two week high of $219.71. The stock has a market cap of $78.37 billion, a PE ratio of 20.28, a price-to-earnings-growth ratio of 2.42 and a beta of 0.62.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last posted its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, beating the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The firm had revenue of $7.30 billion during the quarter. The firm’s revenue was up 7.6% on a year-over-year basis. Equities research analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 earnings per share for the current fiscal year.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Recommended Stories
- Five stocks we like better than Marsh & McLennan Companies
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
